Disease activity assessment in SLE: do we have the right instruments? (Q36171764)

12 August 2017

1 reference

title

Disease activity assessment in SLE: do we have the right instruments? (English)

1 reference

12 August 2017

1

Michelle Petri

1 reference

PMCID

2095289

12 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

Annals of the Rheumatic Diseases

12 August 2017

1 reference

12 August 2017

66 Suppl 3

1 reference

12 August 2017

iii61-4

1 reference

Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095289

A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095289

Combined oral contraceptives in women with systemic lupus erythematosus.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095289

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095289

Sequential therapies for proliferative lupus nephritis

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095289

Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095289

Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095289

Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2095289

Patterns of disease activity in systemic lupus erythematosus

23 September 2018

1 reference

12 December 2020

Accurately describing changes in disease activity in Systemic Lupus Erythematosus

1 reference

12 December 2020

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

12 December 2020

Cytotoxic therapy in systemic lupus erythematosus. Experience from a single center

1 reference

12 December 2020

Outcome measures to be used in clinical trials in systemic lupus erythematosus

1 reference

12 December 2020

Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2007.078477

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

PMCID

2095289